Pharma and Biotech
Competitors: | Okyo Pharma Limited , Hemogenyx Pharmaceuticals |
Executive Director: | Daniel Gooding |
Independent Non-Executive Director: | Madeleine Kennedy |
Non-Executive Chairman: | Julian Gilbert |
Non-Executive Dir: |
Address: | 6th Floor, 60 Gracechurch Street, London, United Kingdom, EC3V 0HR |
Phone: | +44 (0)1223 627222 |
Website: | https://nuformix.com/ |
Sector: | Pharma and Biotech(LSE) |
ISIN: | GB00BYW79Y38 |
Currency | UK Pounds |
Share Price | 0.11p |
Change Today | 0.008p |
% Change | -6.78 % |
52 Week High | 0.22p |
52 Week Low | 0.048p |
Volume | 20,999,602 |
Shares Issued | 1,669.31m |
Market Cap | £1.84m |
RiskGrade | 322 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
14:47 | 1,241 @ 0.12p |
14:15 | 143,537 @ 0.11p |
13:28 | 100,418 @ 0.11p |
11:28 | 268,385 @ 0.11p |
11:00 | 3,000,000 @ 0.11p |
You are here: research